Trials / Unknown
UnknownNCT02087202
Hyperalgesia and NMDA Receptor Antagonist
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
NMDA receptor is administered and postoperative remote hyperalgesia is investigated.
Detailed description
NMDA receptor is adminstered and postoperative tertiary hyperalgesia is investigated. QST and pain measures for remote hyperalgesia are compared between control and magnesium or ketamine group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Sulfate | magnesium sulfate is added to the patients |
| DRUG | ketamine | ketamine is added to the patients. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2014-03-14
- Last updated
- 2014-03-14
Source: ClinicalTrials.gov record NCT02087202. Inclusion in this directory is not an endorsement.